Thrombolisis in acute Myocardial Infarction. Celia Sánchez Manduley Hospital, October-December 2017

Se realizó un estudio descriptivo retrospectivo transversal mediante la revisión de los expedientes clínicos de los 54 pacientes que estuvieron ingresados en el Hospital “Celia Sánchez Manduley” con el diagnóstico de Infarto Agudo del Miocardio (IMA) en el período octubre-diciembre del 2017, para conocer los beneficios más relevantes del tratamiento trombolítico. Se comprobó que los principales factores que retardan el tratamiento trombolítico con eficacia en las enfermedades coronarias (IMA) fueron: la llegada del paciente fuera del tiempo establecido (29,2 %); la hipotensión arterial (9,75 %) y las arritmias (14,6 %); además se observaron signos relevantes de reperfusión y una evolución excelente en los pacientes con óptimo tiempo dolor-aguja (< 2 horas), donde los pacientes trombolizados respondieron favorablemente (23,00 %); mientras que la evolución favorable de los que fueron trombolizados y su tiempo dolor-aguja se comportó al 31,48 %. La información obtenida se procesó en una base de datos mediante el paquete estadístico SPSS 11.5 y se expuso en tablas para su mejor análisis y discusión de los resultados.A descriptive cross sectional, retrospective study was carried out by reviewing the clinical histories of 54 patients who were admitted to Celia Sánchez Manduley hospital with acute Myocardial Infarction diagnosis (AMI) in the period October-December 2017, to know the most relevant benefits of. Thrombolytic treatment with efficacy in coronary diseases were: the arrival of the patient outside the established time (29,2 %); the  arterial hypotension (9,75 %) and the arrhythmias (14,6 %); also relevants signs of  reperfusion were observed and an excellent evolution in patient with optimal pain-needle time (2 hours) where the thrombolyzed patients answered favorably (23,00 %) while the favorable evolution of those who were thrombolyzed and their pain-needle time was behaved to (31,48%). The information was processed in a data by means of statistical package SPSS 11,5 and it was presented in tables for a better analysis and discussion of the results

Escrituras en devenir

El cuarto número de la colección "Laboratorio Transmedia" (ISSN: 2794-0861) contiene textos escritos durante el curso 2022/2023 en el laboratorio internacional "Escrituras en devenir", coordinado por Manuel Broullón y Maximiliano de la Puente con estudiantes y artistas de Argentina, Brasil, España y Venezuela.Unidad Dptal. de Literatura y MediosDepto. de Literaturas Hispánicas y BibliografíaFac. de Ciencias de la InformaciónFac. de FilologíaTRUEUniversidad Complutense de Madridpu

Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI) : a phase 3, placebo-controlled, randomised trial

Background: Patients with stable coronary artery disease and diabetes with previous percutaneous coronary intervention (PCI), particularly those with previous stenting, are at high risk of ischaemic events. These patients are generally treated with aspirin. In this trial, we aimed to investigate if these patients would benefit from treatment with aspirin plus ticagrelor. Methods: The Effect of Ticagrelor on Health Outcomes in diabEtes Mellitus patients Intervention Study (THEMIS) was a phase 3 randomised, double-blinded, placebo-controlled trial, done in 1315 sites in 42 countries. Patients were eligible if 50 years or older, with type 2 diabetes, receiving anti-hyperglycaemic drugs for at least 6 months, with stable coronary artery disease, and one of three other mutually non-exclusive criteria: a history of previous PCI or of coronary artery bypass grafting, or documentation of angiographic stenosis of 50% or more in at least one coronary artery. Eligible patients were randomly assigned (1:1) to either ticagrelor or placebo, by use of an interactive voice-response or web-response system. The THEMIS-PCI trial comprised a prespecified subgroup of patients with previous PCI. The primary efficacy outcome was a composite of cardiovascular death, myocardial infarction, or stroke (measured in the intention-to-treat population). Findings: Between Feb 17, 2014, and May 24, 2016, 11 154 patients (58% of the overall THEMIS trial) with a history of previous PCI were enrolled in the THEMIS-PCI trial. Median follow-up was 3·3 years (IQR 2·8–3·8). In the previous PCI group, fewer patients receiving ticagrelor had a primary efficacy outcome event than in the placebo group (404 [7·3%] of 5558 vs 480 [8·6%] of 5596; HR 0·85 [95% CI 0·74–0·97], p=0·013). The same effect was not observed in patients without PCI (p=0·76, p interaction=0·16). The proportion of patients with cardiovascular death was similar in both treatment groups (174 [3·1%] with ticagrelor vs 183 (3·3%) with placebo; HR 0·96 [95% CI 0·78–1·18], p=0·68), as well as all-cause death (282 [5·1%] vs 323 [5·8%]; 0·88 [0·75–1·03], p=0·11). TIMI major bleeding occurred in 111 (2·0%) of 5536 patients receiving ticagrelor and 62 (1·1%) of 5564 patients receiving placebo (HR 2·03 [95% CI 1·48–2·76], p<0·0001), and fatal bleeding in 6 (0·1%) of 5536 patients with ticagrelor and 6 (0·1%) of 5564 with placebo (1·13 [0·36–3·50], p=0·83). Intracranial haemorrhage occurred in 33 (0·6%) and 31 (0·6%) patients (1·21 [0·74–1·97], p=0·45). Ticagrelor improved net clinical benefit: 519/5558 (9·3%) versus 617/5596 (11·0%), HR=0·85, 95% CI 0·75–0·95, p=0·005, in contrast to patients without PCI where it did not, p interaction=0·012. Benefit was present irrespective of time from most recent PCI. Interpretation: In patients with diabetes, stable coronary artery disease, and previous PCI, ticagrelor added to aspirin reduced cardiovascular death, myocardial infarction, and stroke, although with increased major bleeding. In that large, easily identified population, ticagrelor provided a favourable net clinical benefit (more than in patients without history of PCI). This effect shows that long-term therapy with ticagrelor in addition to aspirin should be considered in patients with diabetes and a history of PCI who have tolerated antiplatelet therapy, have high ischaemic risk, and low bleeding risk

Measurement of charged jet cross section in pp collisions at √s = 5.02 TeV

The cross section of jets reconstructed from charged particles is measured in the transverse momentum range of 5<pT<100 GeV/c in pp collisions at the center-of-mass energy of s√=5.02 TeV with the ALICE detector. The jets are reconstructed using the anti-kT algorithm with resolution parameters R=0.2, 0.3, 0.4, and 0.6 in the pseudorapidity range |η|<0.9−R. The charged jet cross sections are compared with the leading order (LO) and to next-to-leading order (NLO) perturbative Quantum ChromoDynamics (pQCD) calculations. It was found that the NLO calculations agree better with the measurements. The cross section ratios for different resolution parameters were also measured. These ratios increase from low pT to high pT and saturate at high pT, indicating that jet collimation is larger at high pT than at low pT. These results provide a precision test of pQCD predictions and serve as a baseline for the measurement in Pb−Pb collisions at the same energy to quantify the effects of the hot and dense medium created in heavy-ion collisions at the LHC

Publisher Correction: Unveiling the strong interaction among hadrons at the LHC

Correction to: Nature https://doi.org/10.1038/s41586-020-3001-6Published online 09 December 2020 In Fig. 1c of this Article, owing to an error during the production process, the equation incorrectly began ‘C(k*, r*) = …’ instead of ‘C(k*) = …’. In addition, in affiliation 71 ‘Dipartimento di Fisica dell’Università degli studi di Bari Aldo Moro’ has been corrected to read ‘Dipartimento di Fisica dell’Università degli studi di Cagliari’. The original Article has been corrected online

Multiplicity dependence of π, K, and p production in pp collisions at √s = 13 TeV

This paper presents the measurements of π±, K±, p and p¯ transverse momentum (pT) spectra as a function of charged-particle multiplicity density in proton-proton (pp) collisions at s√ = 13 TeV with the ALICE detector at the LHC. Such study allows us to isolate the center-of-mass energy dependence of light-flavour particle production. The measurements reported here cover a pT range from 0.1 GeV/c to 20 GeV/c and are done in the rapidity interval |y|<0.5. The pT-differential particle ratios exhibit an evolution with multiplicity, similar to that observed in pp collisions at s√ = 7 TeV, which is qualitatively described by some of the hydrodynamical and pQCD-inspired models discussed in this paper. Furthermore, the pT-integrated hadron-to-pion yield ratios measured in pp collisions at two different center-of-mass energies are consistent when compared at similar multiplicities. This also extends to strange and multi-strange hadrons, suggesting that, at LHC energies, particle hadrochemistry scales with particle multiplicity the same way under different collision energies and colliding systems

Measurements of the groomed jet radius and momentum splitting fraction with the soft drop and dynamical grooming algorithms in pp collisions at √s = 5.02 TeV

This article presents measurements of the groomed jet radius and momentum splitting fraction in pp collisions at s√=5.02 TeV with the ALICE detector at the Large Hadron Collider. Inclusive charged-particle jets are reconstructed at midrapidity using the anti-kT algorithm for transverse momentum 60<pchjetT<80 GeV/c. We report results using two different grooming algorithms: soft drop and, for the first time, dynamical grooming. For each grooming algorithm, a variety of grooming settings are used in order to explore the impact of collinear radiation on these jet substructure observables. These results are compared to perturbative calculations that include resummation of large logarithms at all orders in the strong coupling constant. We find good agreement of the theoretical predictions with the data for all grooming settings considered

Measurement of isolated photon–hadron correlations in √sNN = 5.02 TeV pp and p–Pb collisions

This paper presents isolated photon-hadron correlations using pp and p-Pb data collected by the ALICE detector at the LHC. For photons with |η| < 0.67 and 12 < pT < 40 GeV/c, the associated yield of charged particles in the range |η| < 0.80 and 0.5 < pT < 10 GeV/c is presented. These momenta are much lower than previous measurements at the LHC. No significant difference between pp and p-Pb is observed, with PYTHIA 8.2 describing both data sets within uncertainties. This measurement constrains nuclear effects on the parton fragmentation in p-Pb collisions, and provides a benchmark for future studies of Pb-Pb collisions